Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) EBT (2016 - 2026)

Champions Oncology (CSBR) has 16 years of EBT data on record, last reported at $255000.0 in Q4 2025.

  • For Q4 2025, EBT fell 65.49% year-over-year to $255000.0; the TTM value through Oct 2025 reached $2.4 million, up 470.44%, while the annual FY2025 figure was $4.6 million, 163.3% up from the prior year.
  • EBT reached $255000.0 in Q4 2025 per CSBR's latest filing, up from -$452000.0 in the prior quarter.
  • Across five years, EBT topped out at $4.5 million in Q1 2025 and bottomed at -$2.5 million in Q2 2023.
  • Average EBT over 5 years is -$350500.0, with a median of -$246000.0 recorded in 2022.
  • Peak YoY movement for EBT: skyrocketed 1706.25% in 2021, then tumbled 102900.0% in 2023.
  • A 5-year view of EBT shows it stood at $289000.0 in 2021, then crashed by 100.69% to -$2000.0 in 2022, then crashed by 102900.0% to -$2.1 million in 2023, then soared by 135.87% to $739000.0 in 2024, then tumbled by 65.49% to $255000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $255000.0 in Q4 2025, -$452000.0 in Q3 2025, and -$2.0 million in Q2 2025.